| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Interferon and Cytokine Factors Acting on the Human Promyelocytic Leukemia Cell Line HL-601
Cornell University Medical College, Sloan-Kettering Division and the Laboratory of Developmental Hematopolesis, Memorial Sloan-Kettering Cancer Center, New York New York 10021
The human promyelocytic leukemia cell line HL-60 and monoblastic leukemia cell line U937 undergo differentiation when induced by lymphokine and cytokine preparations. Growth inhibition, acquisition of immunoglobulin Fc receptors, increased expression of monocyte-related surface antigens, and an increase in lysosomal enzyme contents accompany maturation induced by
-interferon and other cytokine factors tested. Additionally, increased receptors for chemotactic peptide (fMLPR), increased hydrogen peroxide release in response to phorbol myristic acetate stimulation, and the release of prostaglandins (PGE2 and 6-keto-PGF1a) follow exposure to lymphokine and cell line sources of myeloid colony-stimulating activity (CSA).
-Interferon (
-IFN) induced fMLPR in HL-60 (only at 1000 units/ml) but not in U937. Additionally,
-IFN did not induce prostaglandin release in either cell line. These myeloid colony-stimulating activity-associated differentiation-inducing factors were obtained from the human heptoma cell line SK-Hep and bladder carcinoma cell line 5637, which were free of interferon activity. The 2-day phytohemagglutinin-induced lymphokine contained no detectable CSA and was a good source of differentiation activity. A simple, rapid assay for a new human CSA with pluripotent hematopoietic stimulating activity (pluripoietin) is described based on stimulation of [3H]glucosamine incorporation. Cell line conditioned media containing pluripoietin, purified pluripoietin, and
-IFN are active in this assay. These myeloid leukemia cell line differentiation factors are thus different from interferon and conventional CSA. These results suggest that endogenous human cytokines may have a role in the differentiation of leukemic as well as normal myeloid cells.
1 This work was supported by the American Cancer Society Grant CH-3F, NIH Grants CA 33484, CA 32516, HL 31780, and K08 CA00966, and the Gar Riechman Foundation.
2 To whom requests for reprints should be addressed, at Dept. of Developmental Hematopolesis, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
3 Current address: Cetus Corporation, 1400 E. 53rd St., Emeryville, CA 94603.
4 Current address: Department of Nutrition, Cook College, P.O. Box 231, Rutgers University, New Brunswick, NJ 08903.
Received 1/ 8/85. Revised 4/ 3/85. Accepted 4/ 5/85.
This article has been cited by other articles:
![]() |
H. Hovhannisyan, B. Cho, P. Mitra, M. Montecino, G. S. Stein, A. J. van Wijnen, and J. L. Stein Maintenance of Open Chromatin and Selective Genomic Occupancy at the Cell Cycle-Regulated Histone H4 Promoter during Differentiation of HL-60 Promyelocytic Leukemia Cells Mol. Cell. Biol., February 15, 2003; 23(4): 1460 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Kyono, R. de Jong, R. Kil Park, Y. Liu, N. Heisterkamp, J. Groffen, and D. L. Durden Differential Interaction of Crkl with Cbl or C3G, Hef-1, and {gamma} Subunit Immunoreceptor Tyrosine-Based Activation Motif in Signaling of Myeloid High Affinity Fc Receptor for IgG (Fc{gamma}RI) J. Immunol., November 15, 1998; 161(10): 5555 - 5563. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |